Apollo Endosurgery logo — company profile

Apollo Endosurgery

Founded 2006 United States Austin, United States 170 employees Post Ipo Debt Total: $433.53M Biotechnology, Health Care +1

General Information

Company Name Apollo Endosurgery
Founded Year 2006
Location United States Austin, United States +1
Founders / Decision Makers
Jeffrey G. Black  — Chief Financial Officer David M. Hooper  — Vice President- Quality and Regulatory Affairs
Employees 170
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Post Ipo Debt
Social

Get notified when Apollo Endosurgery moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Apollo Endosurgery

Apollo Endosurgery, Inc. is a medical technology company founded in 2006 and focused on developing next-generation, less invasive devices for therapeutic endoscopy. Their devices are designed to treat various gastrointestinal conditions, such as closure of defects, managing complications, and treating obesity. Offering products in over 75 countries, the company's innovative therapies, including the OverStitch™ Endoscopic Suturing System and the ORBERA® Intragastric Balloon, provide alternatives to invasive surgical procedures, thus reducing complication rates and healthcare costs. Notably, Apollo Endosurgery recently received a $35.00M post-IPO debt investment from Innovatus Capital Partners on 21 December 2021. This strategic investment marks an exciting phase for the company, reflecting confidence in its potential for growth and innovation in the biotechnology and health care sectors.

Funding Rounds & Investors (13)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt $35.00M 1 21 Dec 2021
Post-IPO Equity $65.00M - 12 Oct 2021
Post-IPO Debt $20.00M 1 Craig-Hallum Capital Group 13 Aug 2019
Post-IPO Equity $23.70M - 22 Jun 2018
Convertible Note $22.00M 1 PTV Healthcare Capital 01 Nov 2015

View All 13 Funding Rounds

Apollo Endosurgery Alternatives & Competitors

Apollo Endosurgery vs

We developed EndoZip™, a minimally-invasive automated endoscopic suturing system to safely & effecti...

Series B
31 employees
Medical Devices
Apollo Endosurgery vs

Innovation in scope

91 employees
Health Care, Medical Devices
Apollo Endosurgery vs

Easier. Safer. Faster!

6 employees
Health Care, Manufacturing

FAQ About Apollo Endosurgery

Apollo Endosurgery, Inc. is a medical technology company focused on development of next-generation, less invasive devices to advance therapeutic endoscopy designed to treat a variety of gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications...
Apollo Endosurgery was founded in 2006.
Apollo Endosurgery is headquartered in Austin, United States.
Apollo Endosurgery operates in the following industries: Biotechnology, Health Care, Medical Devices.
Apollo Endosurgery has approximately 170 employees.
Apollo Endosurgery has completed 13 funding rounds, raising a total of $433.53M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Apollo Endosurgery include Nitinotes Surgical, Ovesco Endoscopy AG, ErgoSuture/Roller-Based Suturing, Medynus, Inc. , American Society for Gastrointestinal Endoscopy (ASGE). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Apollo Endosurgery and Nitinotes Surgical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Apollo Endosurgery and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy